Movement Alert|Rocket Lab USA, Inc. Overnight Decline 6.73%, Q2 EPS Misses Estimates and Q3 Margin Guidance Disappoints

Market Focus08:02

On August 11, Rocket Lab USA, Inc. declined 6.73% overnight, trading at $74.22/share, with turnover of $573,900. The sell-off followed the company's mixed Q2 earnings release and weak Q3 profitability guidance.

Rocket Lab reported Q2 revenue of $234.1 million, up 62% year-over-year and slightly beating the $231.6 million consensus estimate. However, EPS came in at a loss of $0.08, missing analyst expectations of a $0.06-$0.07 loss. More critically, the company guided Q3 GAAP gross margin at 29%-31%, significantly below the Street's 37.6% estimate, citing shifts in product sales mix. Management also signaled potential new delays for the Neutron rocket program, a key long-term growth driver.

On the positive side, backlog reached a record $2.36 billion with over 90 launch missions pending, and Q3 revenue guidance of $250-$265 million exceeded the $238.5 million consensus. The company recently secured over $660 million in defense contracts, including a $397 million US Space Force Flatellites deal and a $266 million missile defense launch contract.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment